169 related articles for article (PubMed ID: 17014818)
1. Inhibition of ovarian cancer growth and implantation by paclitaxel after laparoscopic surgery in a mouse model.
Lee CL; Kay N
Am J Obstet Gynecol; 2006 Nov; 195(5):1278-81. PubMed ID: 17014818
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor implantation after laparoscopy by specific oligopeptides: a novel approach to adjuvant intraperitoneal therapy to prevent tumor implantation in an animal model.
Jurczok A; Schneider A; Fornara P
Eur Urol; 2007 Aug; 52(2):590-5. PubMed ID: 17097215
[TBL] [Abstract][Full Text] [Related]
3. Reducing peritoneal vascular endothelial growth factor concentration and inhibiting cancer scattering in a mouse model of laparoscopy.
Yen CF; Lee CL; Murk W; Han CM; Liao SK
Am J Obstet Gynecol; 2008 Apr; 198(4):423.e1-7. PubMed ID: 18241828
[TBL] [Abstract][Full Text] [Related]
4. Experimental study of the effect of intraperitoneal heparin on tumour implantation following laparoscopy.
Neuhaus SJ; Ellis T; Jamieson GG; Watson DI
Br J Surg; 1999 Mar; 86(3):400-4. PubMed ID: 10201788
[TBL] [Abstract][Full Text] [Related]
5. The development of a novel intraperitoneal tumor-seeding prophylactic.
Demetrick JS; Liggins RT; Machan L; Davis NL; Burt HM; Hunter WL
Am J Surg; 1997 May; 173(5):403-6. PubMed ID: 9168076
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal closure reduces port site metastases: results of an experiment in a rat ovarian cancer model.
Agostini A; Robin F; Jais JP; Aggerbeck M; Vildé F; Blanc B; Lécuru F
Surg Endosc; 2002 Feb; 16(2):289-91. PubMed ID: 11967680
[TBL] [Abstract][Full Text] [Related]
7. Hematogenous spread as a mechanism for the generation of abdominal wound metastases following laparoscopy.
Brundell S; Ellis T; Dodd T; Watson DI; Hewett PJ
Surg Endosc; 2002 Feb; 16(2):292-5. PubMed ID: 11967681
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis.
Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H
Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000
[TBL] [Abstract][Full Text] [Related]
9. Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors.
Ho EA; Soo PL; Allen C; Piquette-Miller M
J Control Release; 2007 Jan; 117(1):20-7. PubMed ID: 17113177
[TBL] [Abstract][Full Text] [Related]
10. Tumor implantation during laparoscopy using different insufflation gases - an experimental study using cultured cancer cells.
Ludemann ; Watson ; Smith ; Ellis ; Jamieson
Minim Invasive Ther Allied Technol; 2003 Nov; 12(6):310-4. PubMed ID: 16754115
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model.
Hu L; Hofmann J; Holash J; Yancopoulos GD; Sood AK; Jaffe RB
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6966-71. PubMed ID: 16203789
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
Ohashi N; Kodera Y; Nakanishi H; Yokoyama H; Fujiwara M; Koike M; Hibi K; Nakao A; Tatematsu M
Int J Oncol; 2005 Sep; 27(3):637-44. PubMed ID: 16077911
[TBL] [Abstract][Full Text] [Related]
13. Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle--a new strategy against peritoneal dissemination of gastric cancer.
Yamada J; Kitayama J; Tsuno NH; Yamashita H; Miyato H; Soma D; Otani K; Kamei T; Ishigami H; Hidemura A; Kaisaki S; Takahashi K; Nagawa H
Cancer Lett; 2008 Dec; 272(2):307-15. PubMed ID: 18768251
[TBL] [Abstract][Full Text] [Related]
14. Excision of laparoscopic port sites increases the likelihood of wound metastases in an experimental model.
Watson DI; Ellis T; Leeder PC; Neuhaus SJ; Dodd T; Jamieson GG
Surg Endosc; 2003 Jan; 17(1):83-5. PubMed ID: 12360378
[TBL] [Abstract][Full Text] [Related]
15. Postoperative peritoneal dissemination of ovarian cancer cells is not promoted by carbon-dioxide pneumoperitoneum at low intraperitoneal pressure in a syngenic mouse laparoscopic model with controlled respiratory support: a pilot study.
Bourdel N; Matsuzaki S; Bazin JE; Darcha C; Pouly JL; Mage G; Canis M
J Minim Invasive Gynecol; 2008; 15(3):321-6. PubMed ID: 18439505
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
18. [Intraoperative and postoperative intra-peritoneal administration of peptide PIII inhibits peritoneal metastasis of gastric cancer].
Bai FH; Yang L; Ji Q; Zhang YQ; Liu ZX; Wang ZZ; Yan L; Wang JB; Jin HF; Li TT
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3260-3. PubMed ID: 17313805
[TBL] [Abstract][Full Text] [Related]
19. Influence of pneumoperitoneum on tumor growth and pattern of intra-abdominal tumor spreading: in vivo study of a murine model.
Shen MY; Huang IP; Chen WS; Chang JT; Lin JK
Hepatogastroenterology; 2008; 55(84):947-51. PubMed ID: 18705304
[TBL] [Abstract][Full Text] [Related]
20. The effect of pneumoperitoneum on dissemination and scar implantation of intra-abdominal tumor cells.
Tsivian A; Shtabsky A; Issakov J; Gutman M; Sidi AA; Szold A
J Urol; 2000 Dec; 164(6):2096-8. PubMed ID: 11061934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
